USA – RxRevu, a Denver, CO-based Prescription Decision Support company, closed its Series B funding round, raising $7m.
The round was led by JAZZ Venture Partners, with additional investments from existing strategic health system partners. The funding, which brought total investment in the company to $28m, will be used to develop the company’s technology platform SwiftRx®, and facilitate growth in personnel and technical capabilities.Led by Carm Huntress, CEO, RxRevu provides SwiftRx, which brings patient-specific data from pharmacy benefit managers (PBM) to electronic health records (EHR), displaying accurate, real-time information so providers can prescribe low-cost medication options for their patients. The solution also displays coverage and benefit details within the EHR so providers can reduce prior authorization volumes and downstream administrative work.27/01/2021
